HUMALOG 100 UNIT
INSULIN LISPRO : 100 UNIT · DIN 02229704 · ELI LILLY CANADA INC
Health Canada status: MARKETED
What is HUMALOG?
HUMALOG 100 UNIT contains INSULIN LISPRO : 100 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02229704, held by ELI LILLY CANADA INC, supplied as SOLUTION for INTRAVENOUS ; INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 17-Sep-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is HUMALOG used for?
Treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis and for the initial stabilization of diabetes mellitus.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is HUMALOG called?
The same molecule, INSULIN LISPRO, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Actrapid HM (ge) | Latin | South Africa |
| Insuman Rapid | Latin | Norway |
| Humulin NPH | Latin | Norway |
| Humulin NPH KwikPen | Latin | Norway |
| Insuman Infusat | Latin | Norway |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02229704 |
|---|---|
| Brand name | HUMALOG |
| Generic / active ingredient | INSULIN LISPRO : 100 UNIT |
| Manufacturer | ELI LILLY CANADA INC |
| Strength | 100 UNIT |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS ; INTRAMUSCULAR ; SUBCUTANEOUS |
| Schedule | Schedule D |
| ATC code | A10AB04 INSULIN LISPRO |
| AHFS class | 68:20.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 17-Sep-1997 |
| Original market date | 1996-11-27 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02229704 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2229704 |
| Brand name | HUMALOG |
| Active ingredient / INN | INSULIN LISPRO : 100 UNIT |
| ATC code | A10AB04 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A10 |
| AHFS class | 68:20.08 |
| Health Canada schedule | Schedule D |
| Biosimilar biologic | No |
| Market authorization holder | ELI LILLY CANADA INC |
How is it administered?
Dosage determined by physician. HUMALOG should be given within 15 minutes before a meal (or within 20 minutes after starting). HUMALOG 200 units/mL is for patients requiring >20 units/day.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in the provided text snippet (refers to Part III), but generally requires refrigeration.
How is it supplied?
Vials, cartridges, and prefilled pens (KwikPen). (Specific pack sizes like 'bottles of 100' not explicitly detailed in provided text summary).
Which pack is which?
| Strength on the label | 100 UNIT |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS ; INTRAMUSCULAR ; SUBCUTANEOUS |
| Packaging as described in the monograph | Vials, cartridges, and prefilled pens (KwikPen). (Specific pack sizes like 'bottles of 100' not explicitly detailed in provided text summary). |
| Storage | Not explicitly detailed in the provided text snippet (refers to Part III), but generally requires refrigeration. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Contraindications
Contraindicated during episodes of hypoglycemia and in patients sensitive to insulin lispro or any of the excipients.
Warnings and precautions
Hypoglycemia is the most common adverse effect. HUMALOG 200 units/mL must not be used in pumps or mixed with other insulins. Do not transfer 200 units/mL insulin to a syringe.
What can be used instead?
Other Canadian products sharing ATC code A10AB04 INSULIN LISPRO. 8 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ADMELOG | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02469901 |
| ADMELOG | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02469898 |
| ADMELOG SOLOSTAR | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02469871 |
| HUMALOG | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02470152 |
| HUMALOG (CARTRIDGE) | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02229705 |
| HUMALOG (KWIKPEN) | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02403412 |
| HUMALOG 200 UNITS/ML KWIKPEN | 200 UNIT | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02439611 |
| HUMALOG PEN | 100 UNIT | LIQUID | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 02241283 |
| LIPRELOG | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | CANCELLED PRE MARKET | DIN 02513374 |
| LIPRELOG | 100 UNIT | SOLUTION | ELI LILLY CANADA INC | CANCELLED PRE MARKET | DIN 02513331 |
Who else supplies INSULIN LISPRO worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. INSULIN LISPRO appears in 441 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does INSULIN LISPRO cost around the world?
INSULIN LISPRO is listed on 3 national price registers Nexara tracks, across 49 pack listings published on 3 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Greece | producer price (ex-factory) | 41 | 41 | 03 Sep 2026 |
| Norway | max AUP (pharmacy retail) | 5 | 6 | 07 Sep 2026 |
| South Africa | single exit price | 1 | 2 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.